US regulator approves at-home Alzheimer’s drug from Eisai and Biogen ○
found
a story from Financial Times ✅ › Financial Times
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Go ahead for Leqembi shot by Food and Drug Administration could help revive two companies’ sluggish sales